Abstract
This is the first of a four-part Continuing Education series describing current trends in radiopharmaceutical research and development. After reading and studying this article the reader should be able to: 1) discuss the updated approach to brain scintigraphy, 2) discuss characteristics of cerebral perfusion radiopharmaceuticals, and 3) be aware of the prospects of cerebral perfusion imaging in nuclear medicine.